David brings over 35 years of diverse business and scientific expertise to Xeno Biosciences where he is Chief Scientific Officer. He joined Abbott Laboratories in drug discovery and development and then then transitioned to business development and new venture roles including working with startups for the Nutrition division. David held academic appointments in GI/Nutrition at U of Chicago and then in Neonatology at Rush Medical Center following his microbiology degree. He has 100+ peer-reviewed publications with 2000+ citations and numerous successful government filings.